The HCV Synthesis Project: Scope, methodology, and preliminary results

BMC Medical Research Methodology

Volumn 8, Issue , 2008, Pages

  Stern, Rebecca K ^a   Hagan, Holly ^a   Lelutiu Weinberger, Corina ^a   Des Jarlais, Don ^a,b   Scheinmann, Roberta ^a,c   Strauss, Shiela ^d   Pouget, Enrique R ^a   Flom, Peter ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Medical and Health Research Association   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; METHAMPHETAMINE; VIRUS RNA;

ARTICLE; ASIA; AUSTRALIA; CARIBBEAN ISLANDS; COMORBIDITY; DATA ANALYSIS; DRUG ABUSE; EUROPE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; METHODOLOGY; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; NEW ZEALAND; NONHUMAN; NORTH AMERICA; PREVALENCE; RISK FACTOR; SOUTH AMERICA; STATISTICAL ANALYSIS; VIRUS HEPATITIS; WESTERN EUROPE; ADDICTION; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; INFORMATION RETRIEVAL; MALE; META ANALYSIS; PILOT STUDY; REVIEW; SUBSTANCE ABUSE;

EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS C; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MALE; PILOT PROJECTS; RESEARCH DESIGN; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 52249085658     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-8-62     Document Type: Article

References (35)

1. Monitoring hepatitis C virus infection among injecting drug users in the European Union: A review of the literature. K Roy G Hay R Andragetti A Taylor D Goldberg L Wiessing, Epidemiol Infect 2002 129 577 585 10.1017/S0950268802007902 12558341
2. Hepatitis C virus transmission dynamics in injection drug users. H Hagan, Subst Use Misuse 1998 33 1197 1212 9596383
3. Hepatitis C among noninjecting drug users: A report. S Tortu A Neaigus J McMahon D Hagen, Subst Use and Misuse 2001 36 523 534 10.1081/JA-100102640
4. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. CJ Howe CM Fuller DC Ompad S Galea B Koblin D Thomas D Vlahov, Drug Alcohol Depend 2005 79 389 95 10.1016/j.drugalcdep.2005.03.004 16102381
5. Prevention and treatment of hepatitis C in injection drug users. BR Edlin, Hepatology 2002 36 S210 219 12407596 10.1002/hep.1840360727
6. Correlates of Hepatitis C Virus Infections Among Injection Drug Users. DL Thomas D Vlahov L Solomon S Cohn E Taylor R Garfein KE Nelson, Medicine (Baltimore) 1995 74 212 20 10.1097/00005792-199507000-00005 7623656
7. Influence of viral hepatitis on HIV infection. JK Rockstroh, J Hepatol 2006 44 Suppl 1 S25 7 10.1016/j.jhep.2005.11.007
8. Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART. B Lumbreras I Jarrin J del Amo S Perez-Hoyos R Muga M Garcia-de la Hera I Ferreros A Sanvisens I Hurtado Hernandez-Aguado, AIDS 2006 20 111 6 10.1097/01.aids.0000196164. 71388.3b 16327326
9. Epidemiology of the hepatitis C virus among injecting drug users. J Hocking N Crofts C Aitken M MacDonald, Hepatitis C: An Australian perspective Victoria, Australia: IP Communications, Crofts N, Dore G, Locarnini S, (Eds), 2001 260 295
10. Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. C Mathei F Buntinx P van Damme, J Viral Hepat 2002 9 157 73 10.1046/j.1365-2893.2002.00339.x 12010503
11. HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. H Hagan H Thiede DC Des Jarlais, AIDS 2005 19 Suppl 3 S199 S207 10.1097/01.aids.0000192090.61753.d4 16251818
12. A potential hidden source of hepatitis C infection among noninjecting drug users. JM McMahon S Tortu, J Psychoactive Drugs 2003 35 455 60 14986874
13. Non-injection drug use and Hepatitis C Virus: A systematic review. R Scheinmann H Hagan C Lelutiu-Weinberger R Stern D Des Jarlais P Flom S Strauss, Drug Alcohol Depend 2007 89 1 12 17174481 10.1016/j.drugalcdep.2006.11.014
14. National Health and Nutrition Examination Survey III. Centers for Disease Control and Prevention. National Center for Statistics
15. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study. I van Beek R Dwyer GJ Dore K Luo JM Kaldor, BMJ 1998 317 433 437 9703523
16. Sharing of drug preparation equipment as a risk factor for hepatitis C. H Hagan H Thiede NS Weiss SG Hopkins JS Duchin ER Alexander, Am J Public Health 2001 91 42 46 11189822
17. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. LE Thorpe LJ Ouellet R Hershow SL Bailey IT Williams J Williamson ER Monterroso RS Garfein, Am J Epidemiol 2002 155 645 653 10.1093/aje/155.7.645 11914192
18. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. JA Hahn K Page-Shafer PJ Lum K Ochoa AR Moss, Hepatology 2001 34 180 7 10.1053/jhep.2001.25759 11431749
19. Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle/syringe exchange. D Goldberg S Burns A Taylor S Cameron D Hargreaves S Hutchinson, Scand J Infect Dis 2001 33 457 461 10.1080/00365540152029936 11450866
20. Prevalence of hepatitis C among injection drug users in England and Wales: Is harm reduction working? VD Hope A Judd M Hickman T Lamagni G Hunter GV Stimson S Jones L Donovan JV Parry ON Gill, Am J Public Health 2001 91 38 42 11189821
21. Meta-analysis of observational studies in epidemiology: A proposal for reporting. D Stroup J Berlin S Morton I Olkin G Williamson D Rennie D Moher B Becker T Sipe S Thacker for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group, JAMA 2000 283 2008 2012 10.1001/jama.283.15.2008 10789670
22. Transmission of hepatitis C - are noninjecting cocaine users at risk? A Judd M Hickman T Rhodes, Subst Use Misuse 2002 37 573 5 12064440
23. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. DC Des Jarlais T Diaz T Perlis D Vlahov C Maslow M Latka R Rockwell V Edwards SR Fridman E Monterroso I Williams R Garfein, Am J Epidemiol 2003 157 467 71 10.1093/aje/kwf222 12615611
24. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. DC Des Jarlais T Perlis K Arasteh LV Torian H Hagan S Beatrice L Smith J Wethers J Milliken D Mildvan S Yancowitz SR Freidman, AIDS 2005 19 Suppl 3 S20 5 10.1097/01.aids.0000192066.86410.8c 16251819
25. Syringe exchange and risk of infection with hepatitis B and C viruses. H Hagan JP McGough H Thiede NS Weiss S Hopkins ER Alexander, Am J Epidemiol 1999 149 203 13 9927214
26. Sharing of drug preparation equipment as a risk factor for hepatitis C. H Hagan H Thiede NS Weiss SG Hopkins JS Duchin ER Alexander, Am J Public Health 2001 91 42 6 11189822
27. Opportunities for Prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. CL Miller C Johnston PM Spittal K Li N LaLiberte JSG Montaner MT Schecter, Hepatology 2002 36 737 42 10.1053/jhep.2002.35065 12198668
28. The Future Face of Coinfection - Prevalence and Incidence of HIV and Hepatitis C Virus Coinfection Among Young Injection Drug Users. CL Miller E Wood PM Spittal K Li JC Frankish P Braitstein JSG Montaner MT Schecter, JAIDS 2004 36 743 9 15167294
29. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. DM Patrick MW Tyndall PGA Cornelisse K Li C Sherlock M Rekart S Strathdee S Currie M Schecter M O'Shaughnessy, CMAJ 2001 165 889 95 11599327
30. The alive study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods. D Vlahov J Anthony A Munoz J Margdick K Nelson D Celentano L Solomon B Polk, Journal of Drug Issues 1991 21 759
31. The HIV/AIDS Prevention Research Synthesis Project: scope, methods, and study classification results. E Sogolow G Peersman S Semaan D Strouse CM Lyles, JAIDS 2002 30 Suppl 1 S15 29 12107357
32. An examination of the accuracy of self-reported drug use. H Liberty A Taylor, Paper presented at the annual meeting of the American Society of Criminology, Royal York, Toronto, 2006-10-05 http://www.allacademic.com/meta/ p33788_index.html
33. H Cooper L Hedges (Eds), The handbook of research synthesis New York: Russell Sage Foundation 1994
34. Meta-analysis: Spurious Precision? Meta-analysis of obseravtional studies. MSM Egger M Schneider G Smith, BMJ 1998 316 140 4 9462324
35. HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. H Hagan DC Des Jarlais R Stern C Lelutiu-Weinberger R Scheinmann S Strauss P Flom, IJDP